Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Srinivasa R. Ramisetti"'
Autor:
Charyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R. Ramisetti, Preeti Bhadauria, Jacob Schick, Zheng Zeng, Varun Sharma, Wendy Dunton, Sinisa Dovat, Dhimant Desai, Hong Zheng, David J. Feith, Thomas P. Loughran, Shantu Amin, Arun K. Sharma, David Claxton, Arati Sharma
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Acute myeloid leukemia is a heterogeneous disease with a 5-year survival rate of 28.3%, and current treatment options constrained by dose-limiting toxicities. One of the key signaling pathways known to be frequently activated and dysregulated in AML
Externí odkaz:
https://doaj.org/article/91cfc78f3e9d4b93afe1dfa050439f7e
Autor:
Chendil Damodaran, Arun K. Sharma, Nikolay V. Dokholyan, Venkat R. Chirasani, Srinivasa R. Ramisetti, Murali K. Ankem, Cibi A. Sripathi, Becca V. Baby, Venkatesh Kolluru, Balaji Chandrasekaran, Ashish Tyagi
Supplementary Files
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd17fe8a233929b58764f877b0544c7
https://doi.org/10.1158/1535-7163.22519455.v1
https://doi.org/10.1158/1535-7163.22519455.v1
Autor:
Madhu Babu Battu, Srinivasa R. Ramisetti, Raghavendra Gowda, Yu Chi Chen, Xinghai Xia, Tom Kirchhausen, Susan Hafenstein, Qilong Feng, Pingnian He, Venkat R. Chirasani, Nikolay V. Dokholyan, Kyle B. LaPenna, Shantu Amin, Sung Hyun Cho, Gavin P. Robertson, Arthur Berg, Saketh S. Dinavahi, Arun Sharma
Publikováno v:
Cancer Lett
Targeting the metastatic process to prevent disease dissemination in cancer remains challenging. One step in the metastatic cascade involves cancer cells transiting through the vascular endothelium after inflammation has increased the permeability of
Autor:
Ashish Tyagi, Becca V. Baby, Venkat R. Chirasani, Cibi A. Sripathi, Chendil Damodaran, Murali K. Ankem, Arun Sharma, Venkatesh Kolluru, Balaji Chandrasekaran, Nikolay V. Dokholyan, Srinivasa R. Ramisetti
Publikováno v:
Molecular Cancer Therapeutics. 19:2422-2431
Notch1 activation triggers significant oncogenic signaling that manifests as enhanced metastatic potential and tumorigenesis in colorectal cancer. Novel small-molecule inhibitors, mainly plant-derived analogs, have low toxicity profiles and higher bi
Autor:
Srinivasa R. Ramisetti, Parvesh Singh, Shantu Amin, Arun Sharma, Brian K. Law, Ashona Singh-Pillay, Aruna S. Jaiswal, Satya Narayan
Publikováno v:
European Journal of Medicinal Chemistry
Despite new agent development and short-term benefits in patients with colorectal cancer (CRC), metastatic CRC cure rates have not improved due to high rates of 5-fluorouracil (5-FU)/leucovorin/oxaliplatin (FOLFOX)-resistance and a clinical therapeut
Autor:
Satya Narayan, Srinivasa R. Ramisetti, Shantu Amin, Manoj K. Pandey, Deepkamal N. Karelia, Sang Y. Lee, Arun Sharma
Publikováno v:
European Journal of Medicinal Chemistry. 143:1919-1930
A series of novel thio- and seleno-barbituric acid derivatives were synthesized by varying the substituents at N1 and N3 (ethyl, methyl, allyl, and phenyl), and C5 tethered with dienyl and trienyl moieties attached to substituents such as phenyl, 2-f
Publikováno v:
Polycyclic Aromatic Compounds. 40:88-98
An efficient synthesis of potentially carcinogenic dibenzo[a,l]tetracene 1 and dibenzo[a,j]tetracene 2 has been developed and the synthetic standards were used to establish their environmental presence. The synthesis involves Diels–Alder reaction o
Autor:
Ashish, Tyagi, Balaji, Chandrasekaran, Venkatesh, Kolluru, Becca V, Baby, Cibi A, Sripathi, Murali K, Ankem, Srinivasa R, Ramisetti, Venkat R, Chirasani, Nikolay V, Dokholyan, Arun K, Sharma, Chendil, Damodaran
Publikováno v:
Molecular cancer therapeutics. 19(12)
Autor:
Parvesh Singh, Srinivasa R. Ramisetti, Shantu Amin, Arun Sharma, A. S. Prakasha Gowda, Manoj K. Pandey, Ugir Hossain Sk, Deepkamal N. Karelia
Publikováno v:
European journal of medicinal chemistry. 135
Synthesis and anti-melanoma activity of novel naphthalimide isoselenocyanate (NISC) and naphthalimide selenourea (NSU) analogs are described. The novel agents were screened for growth inhibition of different human melanoma cell lines including those
Autor:
Arun Sharma, Trupti Patel, Arati Sharma, Saumya Iyer, Shantu Amiin, David F. Claxton, Shreya Thakur, Srinivasa R. Ramisetti, Pavan Kumar Dhanyamraju, Charyguly Annageldiyev
Publikováno v:
Cancer Research. 79:358-358
Acute myeloid leukemia (AML) is a heterogeneous disease with percent remission of 35-40% for younger patients and 5-15% for older patients and a survival of 5-10 months if left untreated. This emphasizes the urgent unmet need for new therapeutics in